Price T Rowe Associates Inc Crispr Therapeutics Ag Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Price T Rowe Associates Inc holds 420,695 shares of CRSP stock, worth $21.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

420,695

Previous 600,234 29.91%

Holding current value

$21.8 Million

Previous $40.9 Million 44.46%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $9.19 Million - $12.2 Million	-179,539 Reduced 29.91%	420,695 $22.7 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $16 Million - $23.5 Million	-264,112 Reduced 30.56%	600,234 $40.9 Million
Q4 2023 Feb 14, 2024	SELL	$38.62 - $72.18 $204,338 - $381,904	-5,291 Reduced 0.61%	864,346 $54.1 Million
Q3 2023 Nov 14, 2023	SELL	$45.39 - $59.0 $578,177 - $751,542	-12,738 Reduced 1.44%	869,637 $39.5 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $9.58 Million - $14.9 Million	-220,346 Reduced 19.98%	882,375 $49.5 Million
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $825,207 - $1.13 Million	-20,127 Reduced 1.79%	1,102,721 $49.9 Million
Q4 2022 Feb 14, 2023	SELL	$39.19 - $65.67 $2.53 Million - $4.24 Million	-64,614 Reduced 5.44%	1,122,848 $45.6 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $112 Million - $153 Million	-1,827,089 Reduced 60.61%	1,187,462 $77.6 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $79.9 Million - $136 Million	1,848,437 Added 158.51%	3,014,551 $183 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $4.01 Million - $5.97 Million	75,301 Added 6.9%	1,166,114 $73.2 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $6.58 Million - $10.5 Million	-93,916 Reduced 7.93%	1,090,813 $82.7 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $500,748 - $711,772	-4,544 Reduced 0.38%	1,184,729 $133 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $11 Million - $17.7 Million	-109,056 Reduced 8.4%	1,189,273 $193 Million
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $52.7 Million - $100 Million	-476,107 Reduced 26.83%	1,298,329 $158 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $141 Million - $307 Million	1,774,436 New	1,774,436 $272 Million

Others Institutions Holding CRSP

# of Institutions

499

Shares Held

56.8M

Call Options Held

1.7M

Put Options Held

1.8M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Crispr Therapeutics Ag Transaction History